We do have COVID-19 IgG/IgM Immunoassay rapid tests to fight the pandemic

Your Cart is Empty

Improvement as Innovation: Rice-Based Oral Rehydration Solutions

June 08, 2020

Improvement as Innovation: Rice-Based Oral Rehydration Solutions

Almost 1.6 million people died from diarrheal diseases in 2017. 

1.6 million individuals.

And one-third of them were children under five.  

Diarrheal disease, which is predominantly caused by contaminated food and water, strips the body of the water and salts necessary for normal function, resulting in the severe dehydration and fluid loss that are responsible for most diarrhea deaths. The cause of the disease may be viral, bacterial, or parasitic. 

For pregnant women and young children, the potential risks of diarrheal disease are greater. For young children, diarrhea has the ability to exact more harm as they more easily can become dehydrated due to their smaller bodies and fluid reserves. For pregnant women, fluid needs increase “in order to support fetal circulation, amniotic fluid, and a higher blood volume.” Adequate fluid supply helps ensure that a mother can withstand blood loss during delivery. In fact, blood volume increases by 45% on average during pregnancy. Therefore, diarrheal diseases that lead to dehydration can make it impossible for a woman to maintain a healthy pregnancy or ensure a healthy delivery.

Oral Rehydration Solution or Therapy (ORS or ORT) was the product of years of research done in the mid-1900s to alleviate the burden of diarrheal deaths, especially during outbreaks of diseases like cholera. A mixture of water, sugar and salt, ORS helps replace water and electrolytes lost during the course of diarrheal disease. The solution works by taking advantage of what is known as glucose-coupled sodium transport in the small intestine, a system in which glucose aids the transport of sodium, and secondarily, water, out of the intestine and into the body. 

A far cheaper alternative to the traditional IV treatment for diarrhea, ORS has been the "cornerstone of treatment programs to prevent life-threatening dehydration associated with diarrhoea” since the late 1970s. 

However, not all ORS products are the same. Charlene Riikonen, founder of Cera Products Inc., a company that sells ORS products, wanted to produce a more effective ORS. In the early 1990s, after years of working in the field promoting traditional ORS products made with simple sugars, she started Cera Products Inc.

Riikonen’s work with other ORS pioneers in Bangladesh found that rice-based ORSs, as compared to simple sugar ORSs, were far more effective at treating dehydration. She went on to patent her rice-based ORS formula - a formula now used in products sold by Cera around the world, including Ceralyte, Cera’s clinical ORS product line.

Rice-based ORS products have a number of benefits compared to the traditional simple-sugar ORS products. Rice-based products have a lower osmolarity, or particles in the solution, which reduces irritability in the gastrointestinal tract and increases the rate at which fluids are reabsorbed into the body. In addition, rice is absorbed throughout the entire small intestine - as opposed to just the top two-thirds with simple sugars - meaning more water and electrolytes can be absorbed into the body. Through research and field studies, Ceralyte has been shown to be effective in decreasing fluid loss and shortening acute diarrheal sickness. Ceralyte is also certified low FODMAP, making the product accessible to people with irritable bowel syndrome (IBS) and other gastrointestinal issues. 

Ceralyte complies with and exceeds the World Health Organization’s standards as an ORS and is currently being used around the world. 

Innovations like Ceralyte that are built on a commitment to further research and improvement of existing technologies to improve global health are critical to the fight that continues today to eliminate sources of morbidity and mortality that still touch the lives of millions around the globe. 

Check out our 2016 blog post on Oral Rehydration Solutions !

By Mikaela Carrillo


(1) https://ourworldindata.org/diarrheal-diseases

(2) https://www.who.int/en/news-room/fact-sheets/detail/diarrhoeal-disease

(3) https://www.aboutkidshealth.ca/article?contentid=776&language=english

(4) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1595116/

(5) https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.114.009029

(6) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1036912/pdf/medhist00037-0005.pdf

(7) https://rehydrate.org/ors/ort.htm

(8)  https://apps.who.int/iris/bitstream/handle/10665/44174/9789241598415_eng.pdf?sequence=1

(9) https://ceraproductsinc.com/pages/our-story

(10) https://ceraproductsinc.com/pages/the-science-of-cera


Photo Credit

UN Photo/Harandane Dicko

Kabara, Mali

13 March 2017

Photo # 722774

Leave a comment

Comments will be approved before showing up.

Also in The Maternova blog

Helmet CPAP respiratory circuits provide intermediate COVID-19 treatment before ventilators
Helmet CPAP respiratory circuits provide intermediate COVID-19 treatment before ventilators

March 15, 2021

Intermediate solutions to increase positive airway pressure and increase oxygen are in demand in order to keep patients off ventilators and provide an alternative means of treatment when nasal cannula fail and a patient is hypoxemic or at risk of acute respiratory distress syndrome (ARDS).  To put this in a layperson's terms, the pressure exerted by this Helmet CPAP respiratory circuit can actually keep parts of the patients' lungs open, even with very little oxygen flow.
Read More
Are COVID-19 Vaccines Safe for Pregnant Women?
Are COVID-19 Vaccines Safe for Pregnant Women?

March 10, 2021

Read More
Antiretroviral Pouch Leads Innovation in Pediatric HIV Care
Antiretroviral Pouch Leads Innovation in Pediatric HIV Care

February 24, 2021

Read More
News & Updates

Sign up to get the latest on sales, new releases and more …

maternal and newborn health news